Literature DB >> 30663346

The fecal and mucosal microbiome in acute appendicitis patients: an observational study.

Toon Peeters1,2,3,4, John Penders5, Sanne P Smeekens3,4, Gianluca Galazzo5, Bert Houben6, Mihai G Netea3,4, Paul Hm Savelkoul5,7, Inge C Gyssens1,2,3,4.   

Abstract

AIM: We aimed to study the mucosal microbiota of the appendix in a prospective appendicitis cohort and to compare the fecal microbiota of patients and controls. We hypothesized that the microbiota may be associated with susceptibility to appendicitis. PATIENTS &
METHODS: The fecal microbiota of 99 patients and 106 controls were characterized using 16S-23S intergenic spacer profiling. Richness, diversity and community structure were compared. The appendiceal microbiota from 90 patients was analyzed according to the severity of appendicitis.
RESULTS: Overall fecal microbial richness and diversity were similar in patients and controls, yet richness and diversity within the group of Firmicutes, Actinobacteria, Fusobacteria and Verrucomicrobia phyla were lower in patients. Discriminant analyses could correctly classify patients and controls with fair accuracy. No differences were found according to severity in appendiceal or fecal microbiota.
CONCLUSION: This study demonstrates differences in the composition of intestinal microbiota of appendicitis patients and healthy individuals.

Entities:  

Keywords:  acute appendicitis; adult population; dysbiosis; intestinal microbiota; microbiome; prospective cohort study

Mesh:

Substances:

Year:  2019        PMID: 30663346     DOI: 10.2217/fmb-2018-0203

Source DB:  PubMed          Journal:  Future Microbiol        ISSN: 1746-0913            Impact factor:   3.165


  8 in total

1.  Characteristics of appendicitis after immune checkpoint inhibitor therapy among cancer patients.

Authors:  Antony Mathew; Malek Shatila; Zongshan Lai; Dongfeng Tan; Isabella C Glitza Oliva; Jianbo Wang; Omar Alhalabi; Hao Chi Zhang; Anusha Thomas; Yinghong Wang
Journal:  J Cancer Res Clin Oncol       Date:  2022-09-26       Impact factor: 4.322

2.  Impact of Human Genetic Variation on C-Reactive Protein Concentrations and Acute Appendicitis.

Authors:  Isis Ricaño-Ponce; Toon Peeters; Vasiliki Matzaraki; Bert Houben; Ruth Achten; Peter Cools; Mihai G Netea; Inge C Gyssens; Vinod Kumar
Journal:  Front Immunol       Date:  2022-05-25       Impact factor: 8.786

3.  The Gut Microbiota and Inflammatory Factors in Pediatric Appendicitis.

Authors:  Yuewei Bi; Qianyu Yang; Jiao Li; Xufeng Zhao; Beilei Yan; Xuan Li; Hualei Cui
Journal:  Dis Markers       Date:  2022-07-07       Impact factor: 3.464

4.  Acute appendicitis is associated with appendiceal microbiome changes including elevated Campylobacter jejuni levels.

Authors:  Sun Jung Oh; Maya Pimentel; Gabriela G S Leite; Shreya Celly; Maria Jesus Villanueva-Millan; Isabela Lacsina; Brennan Chuang; Gonzalo Parodi; Walter Morales; Stacy Weitsman; Tahli Singer-Englar; Gillian M Barlow; Jing Zhai; Nipaporn Pichestshote; Ali Rezaie; Ruchi Mathur; Mark Pimentel
Journal:  BMJ Open Gastroenterol       Date:  2020-06

5.  Pasteurized Akkermansia muciniphila increases whole-body energy expenditure and fecal energy excretion in diet-induced obese mice.

Authors:  Clara Depommier; Matthias Van Hul; Amandine Everard; Nathalie M Delzenne; Willem M De Vos; Patrice D Cani
Journal:  Gut Microbes       Date:  2020-03-13

6.  An observational study of innate immune responses in patients with acute appendicitis.

Authors:  Toon Peeters; Sandrina Martens; Valentino D'Onofrio; Mark H T Stappers; Jeroen C H van der Hilst; Bert Houben; Ruth Achten; Leo A B Joosten; Inge C Gyssens
Journal:  Sci Rep       Date:  2020-10-15       Impact factor: 4.379

7.  Cluster of Acute Appendicitis Among High School Tibetan Students in Nanchang, China: Investigation, Control, and Prevention.

Authors:  Yitian Guo; Deqiang Ye; Guifang Yang; Guozhen Liu; Xiaochen Cui; Shiyun Tan; Yi Guo
Journal:  Front Public Health       Date:  2022-04-15

8.  Prospective multicentre cohort trial on acute appendicitis and microbiota, aetiology and effects of antimicrobial treatment: study protocol for the MAPPAC (Microbiology APPendicitis ACuta) trial.

Authors:  Sanja Vanhatalo; Eveliina Munukka; Suvi Sippola; Sirpa Jalkanen; Juha Grönroos; Harri Marttila; Erkki Eerola; Saija Hurme; Antti J Hakanen; Paulina Salminen
Journal:  BMJ Open       Date:  2019-09-06       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.